HUTCHMED (China) Limited (AIM:HCM)
London flag London · Delayed Price · Currency is GBP · Price in GBX
169.00
+3.00 (1.81%)
Jul 27, 2026, 4:35 PM GMT

HUTCHMED (China) Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
548.51548.51630.2838426.41356.13
Revenue Growth
-8.91%-12.96%-24.80%96.53%19.73%56.21%
Gross Profit
63.8763.8769.21151.55-271.59-201.19
Operating Income
-39.16-39.16-43.7118.38-407.69-328.32
Net Income
456.91456.9137.73100.78-360.84-194.65
Earnings Per Share
0.520.520.040.12-0.43-0.25
EPS Growth
-1.86%1200.03%-66.28%---

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Ventures
262.97262.97266.84309.38262.57236.52
Oncology/Immunology - Marketed Products
214.36214.36271.53164.17124.64-
Oncology/Immunology - R&D
71.1871.1891.83364.4539.2-
Total
548.51548.51630.2838426.41356.13

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,3691,369837.98889.02633.341,014
Total Debt
97.8997.8989.8286.1327.0138.98
Net Cash (Debt)
1,2711,271748.16802.88606.33975.48
Net Cash Growth
0.48%69.89%-6.82%32.42%-37.84%142.21%
Net Cash Per Share
1.461.460.860.920.721.23

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-64.66-64.660.5219.26-268.6-204.22
Capital Expenditures
-14.15-14.15-17.93-32.61-36.66-16.4
Free Cash Flow
-78.81-78.81-17.44186.65-305.26-220.62
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
11.64%11.64%10.98%18.09%-63.69%-56.49%
Operating Margin
-7.14%-7.14%-6.93%2.19%-95.61%-92.19%
Pretax Margin
95.05%95.05%7.20%12.60%-84.58%-43.56%
Profit Margin
83.30%83.30%5.99%12.03%-84.62%-54.66%
FCF Margin
-14.37%-14.37%-2.77%22.27%-71.59%-61.95%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
4.375.2766.6530.53--
Forward PE
36.3518.81186.78186.78186.78186.78
P/FCF Ratio
---16.48--
PS Ratio
3.574.393.993.676.3017.26